Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

RGD-4C Peptide for Fibronectin Representing, CAS 332179-76-7

RGD-4C, CAS 332179-76-7 US$282.50 Excluding tax and shipping fees In stock Description About RGD-4C, CAS 332179-76-7 RGD-4C, CAS 332179-76-7 is a Peptide representing the fibronectin binding motif for integrins for cancer-targeting research. The RGD-4C, CAS 33

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

RGD-4C, CAS 332179-76-7

US$282.50

Excluding tax and shipping fees

In stock

Description

About RGD-4C, CAS 332179-76-7

RGD-4C, CAS 332179-76-7 is a Peptide representing the fibronectin binding motif for integrins for cancer-targeting research. The RGD-4C, CAS 332179-76-7 Peptide, H-ACDCRGDCFC-OH (cyclic peptide Cys-Cys) from JPT is produced under strict quality control and quality management.

RGD-4C, CAS 332179-76-7- Specifications

Peptide sequence: H-ACDCRGDCFC-OH (cyclic peptide Cys-Cys)

Amount: 5 mg

Purity: > 90% (HPLC/MS)

Counterion: TFA

Delivery Format: Freeze-dried in plastic vial

Application(s): Cancer research

Condition(s)/Topic(s): Cancer

Standard Delivery Time: approx. 3 weeks

RGD Cancer Peptides from JPT

Cancer peptides are widely used to develop targeted diagnostic and therapeutic approaches. They offer different functionalities such as binding tumor-associated receptors, interacting with cellular membranes, or interfering with tumor microenvironment. Depending on the application, these mechanisms enable specific delivery, tumor imaging, and tumor cell killing with low side effects.JPT offers a wide portfolio of high-quality cancer peptides engineered for robust and reproducible research in oncology including RGD and non-RGD cancer peptides.

Benefits of JPT’s RGD Cancer Peptides

Each peptide quality controlled and guaranteed for identity and purity

CoA and HPLC-MS data available

High batch-to-batch consistency

Synthesis protocols designed to avoid toxic contaminants and side products

Provision of freeze dried aliquots for enhanced stability

Proven track record for applications in clinical studies

References

References for RGD-4C, CAS 332179-76-7

ReferencesRead References with Peptides made by JPT

Documentation

Documentation for RGD-4C, CAS 332179-76-7

RGD-4C - CAS 332179-76-7.pdf

Properties

Properties of RGD-4C, CAS 332179-76-7

5 mg

Cancer peptides

Cancer

Freeze-dried in plastic vial

Artificial

Other

>90% (HPLC-MS)

No

Further Information to RGD-4C, CAS 332179-76-7

Values

H-ACDCRGDCFC-OH (cyclic peptide, Cys-Cys)

cyclized RGD cancer peptide

Related Products

Related Products

Cilengitide CAS 188968-51-6

US$1,096.75

iRGD Peptide (cyclo-CRGDKGPDC), CAS 1392278-76-0

US$177.67

GRGDSP, CAS 91037-75-1

Cyclo(-RGDfK), CAS 161552-03-0

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →